DFNA5 inhibitors are a class of chemical compounds that interact with the gasdermin E protein, a protein encoded by the DFNA5 gene. The DFNA5 gene is a member of the gasdermin family, known for its role in various cell processes, including pyroptosis, a type of programmed cell death. Under normal physiological conditions, the DFNA5 gene produces a protein that is typically in an inactive form, but upon cleavage, the N-terminal domain is released, which can form membrane pores. These pores disrupt cellular homeostasis, leading to cell death through ion imbalances and leakage of intracellular components. DFNA5 inhibitors act by binding to specific domains of the gasdermin E protein, preventing its activation or interfering with its pore-forming ability, thereby modulating its role in cellular processes.
The mechanisms by which DFNA5 inhibitors function can vary depending on the molecular architecture of the inhibitor. Some inhibitors are designed to interact directly with the gasdermin E protein, obstructing the cleavage sites or stabilizing the protein in its inactive form. Others may target upstream molecular signals that regulate the activation of DFNA5, thereby indirectly affecting its function. The study of DFNA5 inhibitors is essential for understanding the biochemical pathways that control pyroptosis and other related cellular processes. Since DFNA5 is associated with membrane dynamics, these inhibitors provide a window into the regulation of pore formation and the broader implications of cell membrane integrity and cellular signaling. By exploring these interactions, researchers gain valuable insights into how cell death processes can be controlled at the molecular level through modulation of specific protein functions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This agent could demethylate the promoter region of the DFNA5 gene, leading to transcriptional repression by inducing a less accessible chromatin state. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
By inhibiting histone deacetylases, Trichostatin A may foster hyperacetylation of histones around the DFNA5 locus, which could repress its transcriptional activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid may specifically target histone deacetylases that control the acetylation levels near the DFNA5 gene, potentially reducing its transcription. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
This compound can bind to G-C rich DNA sequences, which could obstruct the binding of essential transcription factors to the DFNA5 promoter, leading to downregulation of the gene. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D, by intercalating into DNA, may specifically hinder the elongation phase of RNA polymerase during DFNA5 gene transcription, leading to decreased mRNA synthesis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Through inhibition of mTOR pathway, Rapamycin could lead to a reduction in cap-dependent translation, potentially decreasing the synthesis of DFNA5 at the translational level. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY 294002, by inhibiting the PI3K pathway, may lead to a downstream reduction in DFNA5 expression, as this pathway is crucial for the initiation of transcription in some genes. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
By intercalating DNA, Doxorubicin could specifically disrupt the transcriptional machinery at the DFNA5 gene locus, leading to a reduction in gene expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine could alter the endosomal and lysosomal pH balance, which might disrupt the cellular turnover of mRNA including that of the DFNA5 gene, leading to its degradation. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin could downregulate the expression of DFNA5 by inhibiting specific kinases involved in the signaling pathways that promote DFNA5's transcription. | ||||||